LY2624803
Product Specifications
UNSPSC Description
LY2624803 is a 5-HT2A and histamine, H1 receptor antagonist[1][2].
Target Antigen
5-HT Receptor; Histamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Immunology/Inflammation;Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ly2624803.html
Solubility
10 mM in DMSO
Smiles
O=C(C(C)(CN1CCN(CC1)C2=NC3=C(OC4=C2C=CC=C4)C=CC=C3)C)O
Molecular Weight
379.45
References & Citations
[1]Abad VC, et al. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. Drugs Aging. 2018;35(9):791-817.|[2]Zisapel N. Current Phase II investigational therapies for insomnia. Expert Opin Investig Drugs. 2015;24(3):401-411.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-123829/LY2624803-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-123829/
Clinical Information
Phase 2
CAS Number
879409-35-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
